The Belgian Endothelial Surgical Transplant of the Cornea
NCT05436665 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220
Last updated 2026-04-03
Summary
This study is designed as a randomised multicentric parallel group pragmatic trial of Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) versus Descemet Membrane Endothelial Keratoplasty (DMEK) in corneal endothelial decompensation. the purpose is to compare the clinical and patient reported outcomes of both therapies across a broad range of indications.
Conditions
- Corneal Edema
- Corneal Endothelial Disorder
- Fuchs' Endothelial Dystrophy
- Bullous Keratopathy
- Pseudophakic Bullous Keratopathy
Interventions
- PROCEDURE
-
UT-DSAEK
The main incision (3.5-5mm) is created at the corneal limbus or via a cornea-scleral tunnel with 2-3 smaller (approx. 1mm) paracentesis incisions. An ophthalmic viscosurgical device (OVD) or a continuous infusion of water or air can be used to maintain the stability of the anterior chamber, according to the surgeon's preference. The corneal endothelium is scored using a scoring instrument and the central diseased corneal endothelium is removed. Once the anterior chamber is prepared, OVD or air has been removed, then the eye is ready for the new corneal graft. The pre-cut corneal tissue delivered by the bank is then gently rinsed and may be stained with 0.06% trypan blue if required. The tissue is loaded into a glide or injector, and pulled into the anterior chamber using a smooth-tipped micro-forceps (e.g., Busin forceps). Once the graft enters the eye, it is lifted to the posterior cornea. The graft is further centred using air (or SF6 Gas) in the anterior chamber.
- PROCEDURE
-
DMEK
The main incision (2.8-3mm) is created superior or temporally at the corneal limbus and is accompanied by 2-3 smaller paracentesis incisions. An ophthalmic viscosurgical device (OVD) or a continuous infusion of water or air can be used to maintain the stability of the anterior chamber. The corneal endothelium is scored using a scoring instrument and the central diseased corneal endothelium is removed. The DMEK roll is poured into a basin and rinsed. The graft is then stained with 0.06% trypan blue to aid in graft visualization. The graft is loaded into an injector and introduced into the anterior chamber. The graft is unrolled using external manoeuvres and once unrolled, it is lifted to the back of the cornea. The eye is then pressurised with a full air fill from 10 to 120 minutes. The pressure is then reduced and the case is completed by suturing any incisions required.
Sponsors & Collaborators
-
Belgium Health Care Knowledge Centre
collaborator OTHER_GOV -
University Hospital, Antwerp
lead OTHER
Principal Investigators
-
Sorcha Ni Dhubhghaill, MBBCh, PhD · Universitair Ziekenhuis Brussel
-
Carina Koppen, MD, PhD · University Hospital, Antwerp
-
Bernard Duchesne, MD, PhD · University Hospital Liege
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-10
- Primary Completion
- 2028-01-06
- Completion
- 2028-06-06
Countries
- Belgium
Study Locations
More Related Trials
-
Transepithelial Corneal Collagen Cross-linking (CXL) in Treatment of Keratoconus
NCT01181219 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy of Descemet Membrane Transplantation for the Treatment of Fuchs' Endothelial Dystrophy
NCT03275896 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
ICG Angiography in Amniotic Membrane Graft and Conjunctival Autograft After Pterygium Excision
NCT00383825 ·Status: COMPLETED ·Phase: NA
-
Transplantation of Cultivated Corneal Epithelial Sheet in Patients With Ocular Surface Disease
NCT01123044 ·Status: UNKNOWN ·Phase: PHASE3
-
Transplant of Epithelium Conjunctival Human Autologous Cultivated ex Vivo in Amniotic Membrane for the Treatment of Symblepharon
NCT00799526 ·Status: UNKNOWN ·Phase: PHASE1
-
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
NCT06261346 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty
NCT04319848 ·Status: RECRUITING ·Phase: PHASE1
-
Implementation of a Protocol for the Transdifferentiation of Buccal Mucosal Epithelium Into Corneal Epithelium
NCT06265298 ·Status: RECRUITING ·Phase: NA
-
Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency
NCT01756365 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Cultivated Corneal Epithelial Stem Cell for Ocular Surface Reconstruction
NCT01237600 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment of PED With AMT and Autologous Serum
NCT00238862 ·Status: COMPLETED ·Phase: NA
-
Modified Corneal EA With Middle LKP for Severe Corneal Burn
NCT03498846 ·Status: UNKNOWN ·Phase: NA
-
Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment
NCT01765244 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Amniotic Membrane Graft In Syntomathic Bullous Keratopathy
NCT01926535 ·Status: COMPLETED ·Phase: PHASE2
-
Fuchs' Endothelial Dystrophy: Clinical Characteristics, Treatment Outcome, and Pathology
NCT01979250 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Collagen-phosphorylcholine Bioengineered Cornea in Patients Requiring Lamellar Keratoplasty
NCT02277054 ·Status: COMPLETED ·Phase: NA
-
Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty
NCT00450996 ·Status: COMPLETED ·Phase: NA
-
Amniotic Membrane and Anterior Stromal Puncture to the Treatment of Symptomatic Bullous Keratopathy
NCT00659308 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study on Co-transplantation of Autologous Limbal Stem Cells and Corneal Stromal Stem Cells to Repair Corneal Injury
NCT06700655 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Long Term Results of Amniotic Membrane Transplant in Bullous Keratopathy Patients
NCT03450954 ·Status: COMPLETED
-
Cornea Preservation Time Study
NCT01537393 ·Status: COMPLETED ·Phase: PHASE4
-
Recurrence Rate of Mini-SLET vs. Limbal-Conjunctival Autograft in Primary Pterygium Excision
NCT03363282 ·Status: COMPLETED ·Phase: NA
-
Tissue Engineering Conjunctiva for the Treatment of Pterygium and Atretoblepharia
NCT02911532 ·Status: UNKNOWN ·Phase: NA
-
Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries
NCT01075347 ·Status: COMPLETED ·Phase: PHASE1
-
Manual Debridement Vs Phototherapeutic Keratectomy in the Treatment of Corneal Basement Membrane Dystrophy
NCT06618508 ·Status: NOT_YET_RECRUITING ·Phase: NA